✦ LIBER ✦

Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin

✍ Scribed by Venla Loimu; Juhani Collan; Leila Vaalavirta; Leif Bäck; Mika Kapanen; Antti Mäkitie; Mikko Tenhunen; Kauko Saarilahti

Book ID: 118497833
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 149 KB
Volume: 98
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2010.10.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly and 3-weekly cisplatin concurrent

Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer

✍ V. Espeli; E. Zucca; M. Ghielmini; O. Giannini; A. Salatino; F. Martucci; A. Ric 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Sparing of the submandibular glands by i

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer

✍ Kauko Saarilahti; Mauri Kouri; Juhani Collan; Aki Kangasmäki; Timo Atula; Heikki 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Evaluation of patterns of failure and su

Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma

✍ Megan E. Daly; YeeYie Lieskovsky; Todd Pawlicki; Jervis Yau; Harlan Pinto; Micha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 2 views

## Abstract ## Background. Our aim was to correlate patterns of failure with target volume delineations in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity‐modulated radiation therapy (IMRT) and to report subjective xerostomia outcomes after IMRT as compared with

Treatment of patients with unresectable

Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy

✍ R. Mesía; M. Majem; M.P. Barretina Ginesta; R. Galiana; M. Mañós; F. Guedea; A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 316 KB

A phase 2 study of bevacizumab with cisp

A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer

✍ Matthew G. Fury; Nancy Y. Lee; Eric Sherman; Donna Lisa; Katherine Kelly; Brynna 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 888 KB

Intensive sequential chemotherapy with b

Intensive sequential chemotherapy with bleomycin, oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck

✍ Wheeler, Richard H. ;Baker, Shan R. ;Liepman, Marcia K. ;Ensminger, William D. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

Twenty-six patients with advanced squamous cell cancer of the head and neck were treated with bleomycin, Oncovin, mitomycin C, and methotrexate (BOMM) for ten weeks. Partial and nonresponders then received adriamycin, cisplatin, and cyclophosphamide (APC) in a planned sequential program. The respons